| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |